跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SELADIN TABLET 250 mg - HSA Drug Approval Details
Approvals
/
HSA
/
SELADIN TABLET 250 mg
Approved
THERAPEUTIC
SELADIN TABLET 250 mg
YUNG SHIN PHARMACEUTICAL IND CO LTD (TAIWAN)
🇸🇬 Health Sciences Authority
Approval Date
Dec 21, 1995
Approval ID
834f514c0e7f606b
Company
YUNG SHIN PHARMACEUTICAL IND CO LTD (TAIWAN)
Type
Therapeutic
Approval Details
Approval Id
834f514c0e7f606b
Drug Name
SELADIN TABLET 250 mg
Product Name
SELADIN TABLET 250 mg
Approval Number
SIN08485P
Approval Date
1995-12-21
Registrant
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence Holder
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
M01AE02
Atc Item Name
naproxen
Pharma Manufacturer Name
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Active Ingredients
NAPROXEN
250 mg
NAPROXEN
250 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 21, 1995
Approval ID
834f514c0e7f606b
Type
Therapeutic
Back to HSA Approvals